Outpatient Marijuana Treatment for Adolescents

French, Michael T.; Roebuck, M. Christopher; Dennis, Michael L.; Godley, Susan H.; Liddle, Howard A.; Tims, Frank M.

doi:10.1177/0193841x03254349

Cited by 49 publications

(32 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study (Mauser et al 1994) adopted a more comprehensive approach in exploring the monetary benefits associated with substance abuse treatment, including savings related to both health care and crime, but had a relatively small sample size that made detection of statistically significant differences challenging. Other studies incorporated multiple outcome measures like criminal activity, health services utilization, and employment status but were performed with narrowly defined populations (Daley et al 2000; French et al 2002b, 2003; Logan et al 2004) or were focused on particular treatment modalities (Barnett and Hui 2000; French, Salome, and Carney 2002), or insured populations (French, Salome, Krupski et al 2000; Goodman et al 2000; Humphreys and Moos 2001; Parthasarathy et al 2001). …”

mentioning

confidence: 99%

Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”?

Ettner¹,

Huang²,

Evans³

et al. 2005

Health Services Research

143

119

View full text Add to dashboard Cite

Objective. To examine costs and monetary benefits associated with substance abuse treatment. Data Sources. Primary and administrative data on client outcomes and agency costs from 43 substance abuse treatment providers in 13 counties in California during 2000–2001. Study Design. Using a social planner perspective, the estimated direct cost of treatment was compared with the associated monetary benefits, including the client's costs of medical care, mental health services, criminal activity, earnings, and (from the government's perspective) transfer program payments. The cost of the client's substance abuse treatment episode was estimated by multiplying the number of days that the client spent in each treatment modality by the estimated average per diem cost of that modality. Monetary benefits associated with treatment were estimated using a pre–posttreatment admission study design, i.e., each client served as his or her own control. Data Collection. Treatment cost data were collected from providers using the Drug Abuse Treatment Cost Analysis Program instrument. For the main sample of 2,567 clients, information on medical hospitalizations, emergency room visits, earnings, and transfer payments was obtained from baseline and 9‐month follow‐up interviews, and linked to information on inpatient and outpatient mental health services use and criminal activity from administrative databases. Sensitivity analyses examined administrative data outcomes for a larger cohort (N=6,545) and longer time period (1 year). Principal Findings. On average, substance abuse treatment costs $1,583 and is associated with a monetary benefit to society of $11,487, representing a greater than 7:1 ratio of benefits to costs. These benefits were primarily because of reduced costs of crime and increased employment earnings. Conclusions. Even without considering the direct value to clients of improved health and quality of life, allocating taxpayer dollars to substance abuse treatment may be a wise investment.

show abstract

mentioning

confidence: 99%

Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”?

Ettner¹,

Huang²,

Evans³

et al. 2005

Health Services Research

143

119

View full text Add to dashboard Cite

show abstract

“…Costs are updated yearly, and estimates for this study refer to fiscal year 2013. Example questions include “In the past 90 days how many… days have you had to go to the emergency room for a health problem?” “…days were you in an intensive outpatient or day program for your drug or alcohol use?” DATCAP is widely used and was adapted for inclusion in the GAIN (French et al, 2003). …”

Section: 0 Materials and Methodsmentioning

confidence: 99%

Six Month Outcomes of a Peer-Enhanced Community Reinforcement Approach for Emerging Adults with Substance Misuse: A Preliminary Study

Smith

Davis

Ureche

et al. 2016

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Little substance use disorder (SUD) treatment research with emerging adults ages 18–25 has been done in community settings, and it is well-known that peers influence emerging adult substance use. The purpose of this study was to develop and test the feasibility of a peer-enhanced behavioral treatment for emerging adults with substance use problems. Emerging adults (n = 35) received a peer-enhanced version of the Community Reinforcement Approach (Peer-CRA), in which their peers (n = 34) were trained to provide alcohol-specific social support. Both identified clients and peers were interviewed at treatment intake, and again three and six months later. Six month outcomes included days of abstinence adjusted for controlled environment days, social costs due to substance use, and binge drinking days in the past 90 days. Treatments were delivered with high fidelity, and a high proportion of participants were retained in treatment and follow-up assessments. Growth curve analyses revealed that emerging adults and their peers significantly increased their days of abstinence and reduced their binge drinking over time. Larger randomized trials should a) test whether peer-enhanced treatments are efficacious relative to treatment as usual, b) investigate whether secondary benefits exist for non-treatment seeking peers supporting another’s treatment, and c) examine whether proposed mechanisms of change (i.e., peer support and peer reductions in substance use) account for any differences in outcomes.

show abstract

“…Although the literature on substance dependence (and services) and its impact on healthcare utilization and associated costs continues to develop, relatively little of this research has focused specifically on chronic drug users [ 25 ], adolescents [ 32 , 33 ], or women [ 29 , 34 ]. In addition, longitudinal studies commonly have short (≤1 year) time frames and often rely on self-reported healthcare use data.…”

Section: Introductionmentioning

confidence: 99%

Women with comorbid substance dependence and psychiatric disorders in Sweden: a longitudinal study of hospital care utilization and costs

Olsson

Fridell

2015

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundSubstance use disorders are regarded as one of the most prevalent, deadly and costly of health problems. Research has consistently found that the prevalence of other psychiatric disorders among those with substance related disorders is substantial. Combined, these disorders lead to considerable disability and health years lost worldwide as well as extraordinary societal costs. Relatively little of the literature on substance dependence and its impact on healthcare utilization and associated costs has focused specifically on chronic drug users, adolescents or women. In addition, the research that has been conducted relies largely on self-reported data and does not provide long-term estimates of hospital care utilization. The purpose of this study is to describe the long-term (24–32 year) healthcare utilization and it’s associated costs for a nationally representative cohort of chronic substance abusing women (adults and adolescents) remanded to compulsory care between 1997–2000 (index episode). As such, this is the first study investigating healthcare costs for women in compulsory treatment in Sweden.MethodsWomen (n = 227) remanded to compulsory care for substance abuse were assessed at intake and their hospital care utilization was retrieved 5-years post compulsory care from national records. Unit costs for ICD-10 diagnoses were applied to all hospital care used from 1975–2006. Attempts are made to estimate productivity losses associated with hospitalization and premature death.ResultsUpon clinical assessment it was found that a majority of these women had a comorbid psychiatric disorder (primarily personality disorder). The women followed in this study were admitted to hospital five to six times that of the general population and had stays six to eight times that of the general population. Total direct healthcare costs per person over the study period averaged approximately $173,000 and was primarily the result of psychiatric department visits (71 %) and inpatient treatment (98.5 %; detoxification and short-term rehabilitation).ConclusionsWomen placed in compulsory care use more hospital resources than that of the general Swedish population and when compared to international research of hospital care use and substance abuse. Direct hospital costs vary greatly over the life course. Effective services can have significant economic benefit.

show abstract

Outpatient Marijuana Treatment for Adolescents

Cited by 49 publications

References 41 publications

Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”?

Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”?

Six Month Outcomes of a Peer-Enhanced Community Reinforcement Approach for Emerging Adults with Substance Misuse: A Preliminary Study

Women with comorbid substance dependence and psychiatric disorders in Sweden: a longitudinal study of hospital care utilization and costs

Contact Info

Product

Resources

About